Telesis Bio Inc. TBIO
0.00
(0.01)
(100.00%)
as of 25 Sep
- Market cap
- $5.3M
- P/E
- 0.0×
Follow TBIO
Growth Flags
show if company had growth for consecutive years
| Dec '17 | Jan '19 | Dec '19 | Jan '20 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 13.80 | 13.80 | 13.80 | 13.80 | 17.83 | 1.40 | 0.43 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (18.79) | (18.79) | (18.79) | (18.79) | (15.83) | (6.80) | (1.61) |
P/B ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 2.17 | 0.82 | 49.44 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 0.00 | 2.66 | 1.29 | 0.00 |
EV/Sales |
— | 19.27 | 19.27 | 19.27 | 19.27 | 11.61 | 0.52 | (0.08) |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 |
EV/Operating CF |
— | (6.55) | (6.55) | (6.55) | (6.55) | (3.49) | (0.37) | 0.06 |
EV/FCF |
— | (6.45) | (6.45) | (6.45) | (6.45) | (3.33) | (0.33) | 0.06 |
Quick Ratio |
— | 17.79 | 17.79 | 2.80 | 2.80 | 8.88 | 3.67 | 3.09 |
Current Ratio |
— | 18.25 | 18.25 | 3.05 | 3.05 | 9.57 | 4.08 | 3.71 |
Net Debt/EBITDA |
— | (2.38) | (2.38) | (2.27) | 0.69 | 2.06 | 0.56 | 0.46 |
Debt/Assets |
0.00% | 112.70% | 112.70% | 175.86% | 12.78% | 12.12% | 24.19% | 7.69% |
Debt/Equity |
— | (5.82) | (5.82) | (1.86) | (0.13) | 0.16 | 0.42 | 22.76 |
Asset Turnover |
— | 0.25 | 0.12 | 0.20 | 0.24 | 0.15 | 0.28 | 0.36 |
Operating CF/Net income |
— | 0.77 | 0.77 | 0.83 | 0.85 | 0.94 | 0.80 | 0.71 |
Capex/Depreciation |
— | 0.00 | 0.00 | 0.00 | (0.12) | (0.90) | (1.33) | (0.12) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 110.65% | 110.65% | 109.28% | 70.74% | (119.27%) | (70.58%) | (209.49%) | |
| — | (42.84%) | (21.42%) | (54.89%) | (67.04%) | (54.44%) | (49.05%) | (64.60%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | (100.19%) | (129.18%) | 0.00% |
Return on Tangible Assets |
— | (27.13%) | (27.13%) | (117.44%) | (147.08%) | (44.83%) | (100.03%) | (166.37%) |
Average Days of Receivables |
— | 113.34 | 113.34 | 125.77 | 125.77 | 121.14 | 77.84 | 79.41 |
Research and Development Expense of Revenue |
— | 27.43% | 27.43% | 55.12% | 135.72% | 131.00% | 85.51% | 63.60% |
Selling, General and Administrative Expense of Revenue |
— | 32.76% | 32.76% | 32.51% | 168.20% | 228.26% | 140.77% | 125.79% |
Intangible Assets out of Total Assets |
0.00 | 0.16 | 0.16 | 0.22 | 0.22 | 0.14 | 0.21 | 0.07 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.65% | 9.83% | 13.58% | 14.41% |
Graham Net Nets |
— | 0.23 | 0.23 | 0.23 | 0.23 | 0.34 | 0.53 | (3.38) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (17.01%) | (17.01%) | (17.01%) | (17.01%) | (30.19%) | (126.82%) | (413.49%) |
Free Cash Flow Yield |
— | (21.64%) | (21.64%) | (21.64%) | (21.64%) | (19.57%) | (112.66%) | (311.30%) |
Revenue per Share |
— | 0.00 | 0.16 | 0.00 | 23.65 | 10.90 | 16.75 | 16.57 |
Operating CF per Share |
— | 0.00 | (0.22) | 0.00 | (55.31) | (36.22) | (23.63) | (20.89) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | (0.73) | (1.83) | (2.73) | (1.18) |
Free Cash Flow per Share |
— | 0.00 | (0.22) | 0.00 | (56.04) | (38.05) | (26.36) | (22.07) |
Cash per Share |
— | 0.00 | 1.00 | 0.00 | 48.41 | 81.74 | 26.71 | 11.65 |
Shareholders Equity per Share |
— | 0.00 | (0.26) | 0.00 | (91.55) | 89.61 | 28.43 | 0.14 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | (0.26) | 0.00 | (91.55) | 89.61 | 28.43 | 0.14 |
Free Cash Flow |
— | (6.39) | (6.39) | (14.88) | (15.58) | (38.55) | (43.18) | (36.63) |
Working Capital |
— | 29.71 | 29.71 | 11.56 | 11.56 | 83.45 | 41.59 | 22.17 |
Capital Expenditures |
— | (0.08) | (0.08) | (0.20) | (0.20) | (1.85) | (4.47) | (1.96) |
Net Current Asset Value |
— | (14.83) | (14.83) | (35.14) | (35.14) | 67.71 | 20.30 | (39.82) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | 0.03 | 0.17 | 0.16 | 0.07 |
Net Profit Margin |
— | (172.78%) | (172.78%) | (273.87%) | (273.87%) | (352.78%) | (176.68%) | (178.21%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 0.97 | 0.97 | 0.39 | 2.53 | 0.59 | 0.49 | 2.23 |
Cash ROIC |
— | (11.14%) | (11.14%) | (52.95%) | 187.69% | (21.40%) | (41.43%) | (167.96%) |
Accounts Receivable Turnover |
— | 3.22 | 3.22 | 3.50 | 2.90 | 3.72 | 5.77 | 4.65 |
Accounts Payable Turnover |
— | 12.18 | 12.18 | 10.70 | 1.56 | 3.66 | 6.24 | 4.61 |
Inventory Turnover |
— | 8.28 | 8.28 | 24.12 | 4.50 | 4.54 | 5.18 | 3.39 |
Average Days of Payables |
— | 34.74 | 25.21 | 55.15 | 147.31 | 135.25 | 39.92 | 113.52 |
Days of Inventory on Hand |
— | 58.92 | 29.24 | 15.13 | 74.34 | 128.16 | 67.82 | 139.13 |
Average Receivables |
— | 1.49 | 1.49 | 1.88 | 2.27 | 2.97 | 4.76 | 5.92 |
Average Payables |
— | 0.73 | 0.73 | 1.60 | 1.89 | 1.85 | 1.90 | 2.29 |
Average Inventory |
— | 1.07 | 1.07 | 0.71 | 0.66 | 1.48 | 2.28 | 3.11 |
Average Assets |
— | 19.38 | 38.76 | 32.81 | 26.86 | 71.56 | 98.81 | 75.89 |
Average Common Equity |
— | (7.50) | (7.50) | (16.48) | (25.46) | 32.66 | 68.67 | 23.40 |
Columns are period end dates